Amgen Inc. Line of Credit Facility, Commitment Fee Percentage
Amgen Inc. (AMGN) reported Line of Credit Facility, Commitment Fee Percentage of 0.09% for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-10-31.
Financial Statements › Notes › Debt
us-gaap:LineOfCreditFacilityCommitmentFeePercentage · last filed 2026-02-13
- Amgen Inc. line of credit facility, commitment fee percentage for the quarter ending 2023-03-31 was 0.09%.
- Amgen Inc. line of credit facility, commitment fee percentage for fiscal 2022 was 0.10%.
| Period end | Line of Credit Facility, Commitment Fee Percentage 3 month | Line of Credit Facility, Commitment Fee Percentage 6 month | Line of Credit Facility, Commitment Fee Percentage 9 month | Line of Credit Facility, Commitment Fee Percentage 12 month |
|---|---|---|---|---|
| 2023-09-30 | 0.09% 10-Q · filed 2023-10-31 | |||
| 2023-06-30 | 0.09% 10-Q · filed 2023-08-04 | |||
| 2023-03-31 | 0.09% 10-K · filed 2026-02-13 | |||
| 2022-12-31 | 0.10% 10-K · filed 2023-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |